Triasima Portfolio Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
TIM
Triasima Portfolio Management's NVO Position: Q1 2025 in Review
Triasima Portfolio Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 5,693 shares — an estimated $490K sold.
Triasima Portfolio Management first reported a position in NVO in Q4 2020 and held it in 17 quarters. The position peaked at $8.96M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.
- Triasima Portfolio Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
- Triasima Portfolio Management sold 5,693 Novo Nordisk shares in Q1 2025, an estimated $490K.
- Triasima Portfolio Management first reported a position in Novo Nordisk in Q4 2020 and held it in 17 quarters.
- Triasima Portfolio Management's Novo Nordisk position peaked at $8.96M in Q2 2024.
- 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.
Based on Triasima Portfolio Management's 13F filing for Q1 2025, filed 2 May 2025.